Novartis has announced a tender offer to acquire an additional stake of up to approximately 39% in its majority-owned Indian subsidiary, Novartis India, from public shareholders at a price of INR351 per share.
Subscribe to our email newsletter
Successful completion of this offer would raise the stake of Novartis in its Indian subsidiary to nearly 90% from the current level of 50.9%. The offer represents a total value of up to INR4.4 billion.
The offer for these shares is expected to open in May 2009 and is subject to regulatory approvals.
The offer by Novartis, a Group subsidiary, has been made at a premium of 27% to the closing share price of INR275.6 of Novartis India on March 24, 2008 which was the last trading day before this announcement. It also represents a premium of 35% over Novartis India’s average share price during February 2009.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.